LONDON (Reuters) - Shares in London-listed drugmaker AstraZeneca declined as much as 3.6% on Monday, falling to their lowest since July 19. Traders ...
STORY CONTINUES BELOW THESE SALTWIRE VIDEOSLONDON - Shares in London-listed drugmaker AstraZeneca declined as much as 3.6% on Monday, falling to their lowest since July 19.
Traders attributed the move to a report in the Mail on Sunday newspaper saying the drugmaker'sChief Executive Pascal Soriot had said privately to friends and advisers that he may leave the company as soon as next year.AstraZeneca declined to comment on the report.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
AstraZeneca shares fall 3.6% to 7-1/2 week lowLONDON (Reuters) - Shares in London-listed drugmaker AstraZeneca declined as much as 3.6% on Monday, falling to their lowest since July 19. Traders ...
Lire la suite »
AstraZeneca shares fall 3.6% to 7-1/2 week lowLONDON (Reuters) - Shares in London-listed drugmaker AstraZeneca declined as much as 3.6% on Monday, falling to their lowest since July 19. Traders ...
Lire la suite »
China is a challenge not a foe, says British trade ministerLONDON (Reuters) - China should not be described as a foe, but as a
Lire la suite »
China is a challenge not a foe, says British trade ministerLONDON (Reuters) - China should not be described as a foe, but as a
Lire la suite »
AstraZeneca's Tagrisso-chemo combo results raise bar for J&J cancer drug-analystsBy Maggie Fick LONDON (Reuters) - Data released on Monday by AstraZeneca from a late-stage trial combining its blockbuster cancer drug Tagrisso with ...
Lire la suite »
AstraZeneca's Tagrisso-chemo combo results raise bar for J&J cancer drug-analystsBy Maggie Fick LONDON (Reuters) - Data released on Monday by AstraZeneca from a late-stage trial combining its blockbuster cancer drug Tagrisso with ...
Lire la suite »